Pharmaceuticals · Key players

Top Myasthenia Gravis Treatment companies

The 5 key players our Myasthenia Gravis Treatment report profiles, and other companies free public records show in this market.

Key players in Myasthenia Gravis Treatment

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the Myasthenia Gravis Treatment market
#CompanyWebsiteOur reports
1 argenx — 33 reports
2 AstraZeneca astrazeneca.com (opens in a new tab) 957 reports
3 UCB — 231 reports
4 Johnson & Johnson jnj.com (opens in a new tab) 2,376 reports
5 Amgen Inc. amgen.com (opens in a new tab) 693 reports

Also active in Myasthenia Gravis Treatment

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in Myasthenia Gravis Treatment, from free public records
CompanyWhere public records show them
Bausch Health
UCB Biopharma SRL
Novartis AG
Zydus Lifesciences
Impax Laboratories Inc
Cartesian Therapeutics
Rising
Mlv
Gilead Sciences, Inc.
Novitium Pharma
ANI Pharmaceuticals
TG Therapeutics

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.

Top trial sponsors in Myasthenia Gravis Treatment

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. argenx 11 active trials on ClinicalTrials.gov (opens in a new tab)
  2. AstraZeneca 11 active trials on ClinicalTrials.gov (opens in a new tab)
  3. UCB Biopharma SRL 5 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Novartis AG 3 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Johnson & Johnson 3 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Cartesian Therapeutics 3 active trials on ClinicalTrials.gov (opens in a new tab)
  7. Amgen Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  8. Gilead Sciences, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Myasthenia Gravis Treatment reports by place

One report for each place. Each tile opens that place's report.

Regions 7

World report Africa report APAC report Europe report Latin America report Middle East report North America report

Countries 26

Australia report Brazil report Canada report China report Ecuador report Egypt report France report Germany report Hong Kong report India report Italy report Japan report Kenya report Malaysia report Mexico report New Zealand report Philippines report Russia report Saudi Arabia report Singapore report South Africa report Spain report Thailand report UAE report UK report US report

Compare all 33 places for Myasthenia Gravis Treatment, with active trials

Get the full Myasthenia Gravis Treatment report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Buy the full report Request free sample

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.